Paper25257573
Progress towards an HIV cure: update from the 2014 International AIDS Society Symposium.
Anderson JL and 4 others. AIDS Res Hum Retroviruses, 2015. Cited by 20 papers, by iCite.
Cite this record
ConductScience Library. Progress towards an HIV cure: update from the 2014 International AIDS Society Symposium. Papers, record 25257573. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25257573
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Conference Proceedings, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| AIDS Vaccines | Major topic |
| Acquired Immunodeficiency Syndrome | Major topic |
| Anti-HIV Agents | Major topic |
| CD4-Positive T-Lymphocytes | Major topic |
| CD8-Positive T-Lymphocytes | Major topic |
| Antiretroviral Therapy, Highly Active | |
| Biomedical Research | |
| Enzyme Activation | |
| Humans | |
| NF-kappa B | |
| Positive Transcriptional Elongation Factor B | |
| Treatment Outcome | |
| Virus Latency |
Source PubMed
References35
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 22802445 | BET bromodomain inhibition as a novel strategy for reactivation of HIV-1. | J Leukoc Biol | 2012 | https://conductscience.org/library/papers/22802445 | PubMed |
| 2 | 25071766 | Baseline and Dynamic Expression of Activating NK Cell Receptors in the Control of Chronic Viral Infections: The Paradigm of HIV-1 and HCV. | Front Immunol | 2014 | https://conductscience.org/library/papers/25071766 | PubMed |
| 3 | 26423811 | Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1/2, single group, clinical trial. | Lancet HIV | 2014 | https://conductscience.org/library/papers/26423811 | PubMed |
| 4 | 23255218 | BET bromodomain-targeting compounds reactivate HIV from latency via a Tat-independent mechanism. | Cell Cycle | 2013 | https://conductscience.org/library/papers/23255218 | PubMed |
| 5 | 24990883 | Neutralizing antibodies to HIV-1 envelope protect more effectively in vivo than those to the CD4 receptor. | Sci Transl Med | 2014 | https://conductscience.org/library/papers/24990883 | PubMed |
| 6 | 24339779 | Myeloid dendritic cells induce HIV-1 latency in non-proliferating CD4+ T cells. | PLoS Pathog | 2013 | https://conductscience.org/library/papers/24339779 | PubMed |
| 7 | 22837004 | Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy. | Nature | 2012 | https://conductscience.org/library/papers/22837004 | PubMed |
| 8 | 24804860 | Reactivation of HIV latency by a newly modified Ingenol derivative via protein kinase Cδ-NF-κB signaling. | AIDS | 2014 | https://conductscience.org/library/papers/24804860 | PubMed |
| 9 | 24620025 | HIV-1 expression within resting CD4+ T cells after multiple doses of vorinostat. | J Infect Dis | 2014 | https://conductscience.org/library/papers/24620025 | PubMed |
| 10 | 23460751 | Long-term reduction in peripheral blood HIV type 1 reservoirs following reduced-intensity conditioning allogeneic stem cell transplantation. | J Infect Dis | 2013 | https://conductscience.org/library/papers/23460751 | PubMed |
| 11 | 16289657 | The gammac-cytokine regulated transcription factor, STAT5, increases HIV-1 production in primary CD4 T cells. | Virology | 2006 | https://conductscience.org/library/papers/16289657 | PubMed |
| 12 | 20616233 | Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1. | Science | 2010 | https://conductscience.org/library/papers/20616233 | PubMed |
| 13 | 25013066 | A critical question for HIV vaccine development: which antibodies to induce? | Science | 2014 | https://conductscience.org/library/papers/25013066 | PubMed |
| 14 | 24336828 | A pilot study assessing the safety and latency-reversing activity of disulfiram in HIV-1-infected adults on antiretroviral therapy. | Clin Infect Dis | 2014 | https://conductscience.org/library/papers/24336828 | PubMed |
| 15 | 24827152 | Dual role of novel ingenol derivatives from Euphorbia tirucalli in HIV replication: inhibition of de novo infection and activation of viral LTR. | PLoS One | 2014 | https://conductscience.org/library/papers/24827152 | PubMed |
| 16 | 24025770 | Immune clearance of highly pathogenic SIV infection. | Nature | 2013 | https://conductscience.org/library/papers/24025770 | PubMed |
| 17 | 24152233 | Absence of detectable HIV-1 viremia after treatment cessation in an infant. | N Engl J Med | 2013 | https://conductscience.org/library/papers/24152233 | PubMed |
| 18 | 24965460 | Broadly neutralizing antibody VRC01 prevents HIV-1 transmission from plasmacytoid dendritic cells to CD4 T lymphocytes. | J Virol | 2014 | https://conductscience.org/library/papers/24965460 | PubMed |
| 19 | 25038345 | An HIV cure: feasibility, discovery, and implementation. | JAMA | 2014 | https://conductscience.org/library/papers/25038345 | PubMed |
| 20 | 24722454 | Histone deacetylase inhibitor romidepsin induces HIV expression in CD4 T cells from patients on suppressive antiretroviral therapy at concentrations achieved by clinical dosing. | PLoS Pathog | 2014 | https://conductscience.org/library/papers/24722454 | PubMed |
Cited by16
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 20 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 35297660 | Enhanced Cross-Reactive and Polyfunctional Effector-Memory T Cell Responses by ICVAX-a Human PD1-Based Bivalent HIV-1 Gag-p41 Mosaic DNA Vaccine. | J Virol | 2022 | https://conductscience.org/library/papers/35297660 | PubMed |
| 32764508 | Antiretroviral Therapy Interruption (ATI) in HIV-1 Infected Patients Participating in Therapeutic Vaccine Trials: Surrogate Markers of Virological Response. | Vaccines (Basel) | 2020 | https://conductscience.org/library/papers/32764508 | PubMed |
| 32435247 | HIVconsv Vaccines and Romidepsin in Early-Treated HIV-1-Infected Individuals: Safety, Immunogenicity and Effect on the Viral Reservoir (Study BCN02). | Front Immunol | 2020 | https://conductscience.org/library/papers/32435247 | PubMed |
| 32128329 | Virological Outcome Measures During Analytical Treatment Interruptions in Chronic HIV-1-Infected Patients. | Open Forum Infect Dis | 2019 | https://conductscience.org/library/papers/32128329 | PubMed |
| 31941478 | Crowdsourcing contests to facilitate community engagement in HIV cure research: a qualitative evaluation of facilitators and barriers of participation. | BMC Public Health | 2020 | https://conductscience.org/library/papers/31941478 | PubMed |
| 31312806 | Therapeutic Vaccination Refocuses T-cell Responses Towards Conserved Regions of HIV-1 in Early Treated Individuals (BCN 01 study). | EClinicalMedicine | 2019 | https://conductscience.org/library/papers/31312806 | PubMed |
| 30142171 | Perceptions of HIV cure research among people living with HIV in Australia. | PLoS One | 2018 | https://conductscience.org/library/papers/30142171 | PubMed |
| 29141633 | Genome modification of CXCR4 by Staphylococcus aureus Cas9 renders cells resistance to HIV-1 infection. | Retrovirology | 2017 | https://conductscience.org/library/papers/29141633 | PubMed |
| 28953921 | Virological and immunological outcome of treatment interruption in HIV-1-infected subjects vaccinated with MVA-B. | PLoS One | 2017 | https://conductscience.org/library/papers/28953921 | PubMed |
| 27781107 | The latest science from the IAS Towards an HIV Cure Symposium: 16-17 July 2016, Durban, South Africa. | J Virus Erad | 2016 | https://conductscience.org/library/papers/27781107 | PubMed |
| 27402887 | The social value of candidate HIV cures: actualism versus possibilism. | J Med Ethics | 2017 | https://conductscience.org/library/papers/27402887 | PubMed |
| 27259546 | When to start paediatric testing of the adult HIV cure research agenda? | J Med Ethics | 2017 | https://conductscience.org/library/papers/27259546 | PubMed |
| 26933962 | Which New Health Technologies Do We Need to Achieve an End to HIV/AIDS? | PLoS Biol | 2016 | https://conductscience.org/library/papers/26933962 | PubMed |
| 26907881 | Global strategies are required to cure and eliminate HBV infection. | Nat Rev Gastroenterol Hepatol | 2016 | https://conductscience.org/library/papers/26907881 | PubMed |
| 26561337 | Evaluating the efficacy of therapeutic HIV vaccines through analytical treatment interruptions. | J Int AIDS Soc | 2015 | https://conductscience.org/library/papers/26561337 | PubMed |
| 25835530 | Eradication of HIV-1 from the macrophage reservoir: an uncertain goal? | Viruses | 2015 | https://conductscience.org/library/papers/25835530 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| NFKB1 | 4790 | PubTator's text mining | https://conductscience.org/library/genes/4790 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/25257573
GET https://conductscience.org/api/papers/v1/25257573/references?page=2